Food supplement safety and market entry in Germany, Bulgaria, North Macedonia and China

Summary

This comparative legal and literature review examined food supplement market entry controls in Germany, Bulgaria, North Macedonia, and China, identifying substantial variation in regulatory approaches from notification (Germany) to prior registration (Bulgaria) to compliance opinion plus registration (North Macedonia) to registration with functional assessment (China). The analysis demonstrates that administrative regulatory status alone cannot establish universal safety or therapeutic efficacy, and highlights the importance of total exposure assessment, preparation-specific toxicity data, and continued post-market reassessment. The authors conclude that good regulatory practice requires transparent classification, proportionate evidence requirements, prominent labelling warnings, controlled product changes, and integrated post-market surveillance, whilst noting that Chinese functional assessment frameworks, though distinct, do not demonstrably establish superior health outcomes compared with European approaches.

Regional applicability

This review is directly relevant to United Kingdom food supplement regulation, particularly given the UK's transition away from EU frameworks post-Brexit and ongoing development of independent regulatory standards. The comparison with EU member states (Germany, Bulgaria) provides context for UK alignment or divergence, whilst the Chinese model offers a distinct comparator for evidence-based risk assessment that may inform future UK policy development, though direct transferability is limited by different legal traditions and consumer populations.

Key measures

Regulatory classification systems, evidence requirements, dose ceilings, post-market surveillance mechanisms, and alignment between administrative designation and scientific safety evaluation across jurisdictions.

Outcomes reported

The study compared market entry regulatory controls and safety assessment frameworks for food supplements across four jurisdictions, using vitamin B6, green tea extracts, and red yeast rice as case examples of dose-related toxicity and regulatory responses.

Supporting research

Primary abstract compares food-supplement market-entry and safety frameworks across four jurisdictions and discusses preparation/dose-specific supplement exposure.

Limits: Comparative legal/toxicological documentary review; no comparative health outcome superiority, universal safety or therapeutic efficacy is established. The underlying laws were not independently audited.

Topic tags